Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions

Background: Amyotrophic Lateral Sclerosis (ALS) is a relentlessly progressive neurodegenerative condition with limited therapeutic options at present. Survival from symptom onset ranges from 3 to 5 years depending on genetic, demographic, and phenotypic factors. Despite tireless research efforts, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Grollemund, Vincent, Pradat, Pierre-François, Querin, Giorgia, Delbot, François, Le Chat, Gaétan, Pradat-Peyre, Jean-François, Bede, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403867/
https://www.ncbi.nlm.nih.gov/pubmed/30872992
http://dx.doi.org/10.3389/fnins.2019.00135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403867/
https://www.ncbi.nlm.nih.gov/pubmed/30872992
http://dx.doi.org/10.3389/fnins.2019.00135

Ejemplares similares